Intrajejunal levodopa infusion in advanced Parkinson's disease: Long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 1, 2012, Pages 79-89

  Fasano, A ^a,b   Ricciardi, L ^a,c   Lena, F ^d   Bentivoglio, A R ^a   Modugno, N ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d IRCCS NEUROMED   (Italy)

Author keywords

Caregiver; Intrajejunal levodopa; Non motor symptoms; Parkinson's disease; Quality of life

Indexed keywords

AMANTADINE; APOMORPHINE; BENSERAZIDE PLUS LEVODOPA; CABERGOLINE; CARBIDOPA; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; CLOZAPINE; ENTACAPONE; LEVODOPA; LEVODOPA METHYL ESTER; PRAMIPEXOLE; QUETIAPINE; RASAGILINE; ROPINIROLE; ROTIGOTINE; TOLCAPONE;

ADULT; AGED; CAREGIVER BURDEN; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; COHORT ANALYSIS; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MALE; NON MOTOR SYMPTOMS SCALE; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE; PARKINSON DISEASE SLEEP SCALE; PREDICTION; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RETROSPECTIVE STUDY; REVIEW; SLEEP QUALITY; SOMNOLENCE; STRESS; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTIPARKINSON AGENTS; CAREGIVERS; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; INFUSIONS, PARENTERAL; JEJUNUM; LEVODOPA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84859862768     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. CHAUDHURI KR, HEALY DG, SCHAPIRA AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245. (Pubitemid 43238347)
2. O'SULLIVAN SS, WILLIAMS DR, GALLAGHER DA, MASSEY LA, SILVEIRA-MORIYAMA L, LEES AJ. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2008;23:101-106. (Pubitemid 351281225)
3. SCHRAG A, JAHANSHAHI M, QUINN N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000;15:1112-1118.
4. FINDLEY L, AUJLA M, BAIN PG, BAKER M, BEECH C, BOWMAN C, HOLMES J, KINGDOM WK, MACMAHON DG, PETO V, PLAYFER JR. Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord 2003;18:1139-1145. (Pubitemid 37336937)
5. CARTER JH, STEWART BJ, LYONS KS, ARCHBOLD PG. Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression? Mov Disord 2008;23:1211-1216.
6. NYHOLM D, ASKMARK H, GOMES-TROLIN C, KNUTSON T, LENNERNAS H, NYSTROM C, AQUILONIUS SM. Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets. Clin Neuropharmacol 2003;26:156-163. (Pubitemid 36676295)
7. NYHOLM D, NILSSON REMAHL AI, DIZDAR N, CONSTANTINESCU R, HOLMBERG B, JANSSON R, AQUILONIUS SM, ASKMARK H. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 2005;64:216-223.
8. ANTONINI A, ISAIAS IU, CANESI M, ZIBETTI M, MANCINI F, MANFREDI L, DAL FANTE M, LOPIANO L, PEZZOLI G. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 2007;22:1145-1149. (Pubitemid 47067225)
9. EGGERT K, SCHRADER C, HAHN M, STAMELOU M, RUSSMANN A, DENGLER R, OERTEL W, ODIN P. Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol 2008;31:151-166. (Pubitemid 351787111)
10. ANTONINI A, MANCINI F, CANESI M, ZANGAGLIA R, ISAIAS IU, MANFREDI L, PACCHETTI C, ZIBETTI M, NATUZZI F, LOPIANO L, NAPPI G, PEZZOLI G. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease. Neurodegener Dis 2008;5:244-246. (Pubitemid 351347862)
11. HONIG H, ANTONINI A, MARTINEZ-MARTIN P, FORGACS I, FAYE GC, FOX T, FOX K, MANCINI F, CANESI M, ODIN P, CHAUDHURI KR. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 2009;24:1468-1474.
12. GELB DJ, OLIVER E, GILMAN S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39. (Pubitemid 29046907)
13. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders., 4th ed., text rev. ed. Washington, DC, 2000.
14. TOMLINSON CL, STOWE R, PATEL S, RICK C, GRAY R, CLARKE CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
15. FAHN S, ELTON R, COMMITTEE. MotUD. Recent developments in Parkinson's disease. Folorham Park, NJ: Macmillan Health Care Information, 1987.
16. GILADI N, SHABTAI H, SIMON ES, BIRAN S, TAL J, KORCZYN AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 2000;6:165-170. (Pubitemid 30246070)
17. CHAUDHURI KR, MARTINEZ-MARTIN P, BROWN RG, SETHI K, STOCCHI F, ODIN P, ONDO W, ABE K, MACPHEE G, MACMAHON D, BARONE P, RABEY M, FORBES A, BREEN K, TLUK S, NAIDU Y, OLANOW W, WILLIAMS AJ, THOMAS S, RYE D, TSUBOI Y, HAND A, SCHAPIRA AH. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord 2007;22:1901-1911. (Pubitemid 350134203)
18. CHAUDHURI KR, PAL S, DI MARCO A, WHATELY-SMITH C, BRIDGMAN K, MATHEW R, PEZZELA FR, FORBES A, HOGL B, TRENKWALDER C. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629-635. (Pubitemid 35448845)
19. JENKINSON C, FITZPATRICK R. Cross-cultural evaluation of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain. Parkinsonism Relat Disord 2007;13:22-28. (Pubitemid 46149444)
20. LAWTON M P, BRODY EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
21. FOLSTEIN M F, FOLSTEIN SE, MCHUGH PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. DUBOIS B, SLACHEVSKY A, LITVAN I, PILLON B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621-1626.
23. CUMMINGS JL, MEGA M, GRAY K, ROSENBERG-THOMPSON S, CARUSI DA, GORNBEIN J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314. (Pubitemid 24382728)
24. WEINTRAUB D, HOOPS S, SHEA JA, LYONS KE, PAHWA R, DRIVER-DUNCKLEY ED, ADLER CH, POTENZA MN, MIYASAKI J, SIDEROWF AD, DUDA JE, HURTIG HI, COLCHER A, HORN SS, STERN MB, VOON V. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009;24:1461-1467.
25. GREENE JG, SMITH R, GARDINER M, TIMBURY GC. Measuring behavioural disturbance of elderly demented patients in the community and its effects on relatives: a factor analytic study. Age Ageing 1982;11:121-126. (Pubitemid 12102597)
26. MEROLA A, ZIBETTI M, ANGRISANO S, RIZZI L, LANOTTE M, LOPIANO L. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease. Mov Disord 2011;26:664-670.
27. WEINTRAUB D, KOESTER J, POTENZA MN, SIDEROWF AD, STACY M, VOON V, WHETTECKEY J, WUNDERLICH GR, LANG AE. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-595.
28. VOON V, FOX SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007;64:1089-1096. (Pubitemid 47258066)
29. ARNULF I, LEU-SEMENESCU S. Sleepiness in Parkinson's disease. Parkinsonism Relat Disord 2009;15(Suppl 3):S101-104.
30. HARRISON MB, WYLIE SA, FRYSINGER RC. UPDRS activity of daily living score as a marker of Parkinson's disease progression. Mov Disord 2009;24:224-230.